Allscripts (MDRX) Reports In-Line Q2 EPS, Offers Guidance, Approves $250M Buyback
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Allscripts (MDRX) PT Raised to $16 at Dougherty & Co
August 6, 2018 7:35 AM EDTDougherty & Co raised its price target on Allscripts (NASDAQ: MDRX) to $16.00 (from $15.50) while maintaining a Buy rating.
Analyst Gene Mannheimer said intent to sell NetSmart more than offsets weak bookings quarter.
... MoreAllscripts (MDRX) PT Lowered to $14 at RBC Capital
August 3, 2018 7:20 AM EDTRBC Capital lowered its price target on Allscripts (NASDAQ: MDRX) to $14.00 (from $14.50) while maintaining a Outperform rating.
... More